| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |